Loading quotes...
Forecast
The analysts' average price target is €56.79 (-2.67%). The median is €56.50 (-3.17%).
| Buy |
11 |
| Hold |
17 |
| Sell |
2 |
News Go to news feed
Fortive appoints Susan L. Main to the board
Fortive has appointed Susan L. Main to its board effective Sept. 9, increasing the number of directors from eight to nine. Main was also named to the audit committee and brings experience as the former CFO of Teledyne Technologies as well as board roles at Allegion and Ashland. Chair Shar Dubey and CEO Olumide Soroye highlighted her financial and operational expertise and her relevance to industrial technology. » More on de.investing.com
Fortive: $100 investment three years ago yields 4.26% gain
Three years ago Fortive's closing price was $58.04, and on August 4, 2026 it was $60.51. An investor who put in $100 back then now owns 1.723 shares worth $104.26, an increase of 4.26%. The calculation does not account for stock splits or dividends; Fortive most recently reached a market capitalization of $17.96 billion. » More on finanzen.net
Fortive hits 52-week high at $63.43 and strengthens growth signal
Fortive shares climbed to a 52-week high of $63.43; market capitalization is $19.3 billion and the P/E ratio is 36.88. The company reports a one‑year price gain of 19.64% and high gross margins of 63%, although investment analysts consider the stock to be above fair value. Fortive is acquiring a majority stake in UV Smart to bolster its infection‑prevention business, increasing its buyback program to 20 million shares and declaring a quarterly dividend of $0.06. The company also issued bonds totaling $1.1 billion (maturities 2031 and 2036) and received an upgrade to “buy” from Argus due to improved revenue transparency. » More on de.investing.com
Historical dividends Dividends
All dividend metrics All metricsFinancials
| (EUR) | July 2026 | YoY |
|---|---|---|
| Revenue | 958.5m | 26.04% |
| Gross profit | 607.63m | 20.50% |
| Net profit | 137.47m | 3.30% |
| EBITDA | 282.62m | 0.63% |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €16.69bn |
Number of shares | 302.02m |
52-week high/low | €57.90 - €43.92 |
Dividend yield | 0.38% |
Dividends TTM | €0.22 |
Beta | 0.99 |
P/E ratio | 35.83 |
PEG ratio | -1.57 |
P/B ratio | 3.09 |
P/S ratio | 4.31 |
Company profile
Fortive Corporation designs, develops, manufactures, markets, and services professional and engineered products, software, and services worldwide. Its Intelligent Operating Solutions segment offers connected reliability tools; environment, health, safety, and quality enterprise software products; facility and asset lifecycle software; pre-construction planning and construction procurement solutions; ruggedized professional test tools; electric, pressure, and temperature calibration tools; and portable gas detection tools for a range of vertical end markets including manufacturing, process industries, healthcare, utilities and power, communications and electronics, and others. It markets its products and services under the ACCRUENT, FLUKE, GORDIAN, INDUSTRIAL SCIENTIFIC, INTELEX, PRUFTECHNIK, and SERVICECHANNEL brands. The company's Precision Technologies segment provides electrical test and measurement instruments and services; energetic material devices; and sensor and control system solutions for power and energy, medical equipment, food and beverage, aerospace and defense, off-highway vehicles, electronics, semiconductors, and other general industrial markets. This segment markets its products under the ANDERSON-NEGELE, GEMS, SETRA, HENGSTLER-DYNAPAR, QUALITROL, PACIFIC SCIENTIFIC, KEITHLEY, and TEKTRONIX brands. Its Advanced Healthcare Solutions segment offers hardware and software products and services, including instrument and device reprocessing, instrument tracking, biomedical test tools, radiation safety monitoring, and asset management services; subscription-based surgical inventory management systems to facilitate inventory management and regulatory compliance, as well as technical, analytical, and compliance services to determine radiation exposure services under the ASP, CENSIS, CENSITRAC, EVOTECH, FLUKE BIOMEDICAL, INVETECH, LANDAUER, RAYSAFE, and STERRAD brands. Fortive Corporation was incorporated in 2015 and is headquartered in Everett, Washington.
| Name | FORTIVE CORP. DL-,01 |
| CEO | Olumide O. Soroye |
| Headquarters | Everett,
wa USA |
| Website | |
| Sector | Industrials |
| Industry | Electrical Equipment |
| IPO | 05/07/2016 |
| Employees | 10,000 |
Ticker symbols
| Exchange | Symbol |
|---|---|
NYSE | FTV |
London Stock Exchange | 0IRE.L |
Frankfurt | F03.F |
Düsseldorf | F03.DU |
London | 0IRE.L |
SIX | F03.SW |
München | F03.MU |